{'fraction_non_alphanumeric': 0.023172905525846704, 'fraction_numerical': 0.0, 'mean_word_length': 5.938271604938271, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Pilot study of a novel transmembranous electromyography device for assessment of oral cavity and oropharyngeal muscles

Electromyography (EMG) can provide valuable insights into the pathophysiology of oropharyngeal muscles in various disease states, but the invasive nature of the conventional needle EMG (nEMG) has its limitations in this setting. We aimed to examine the inter‐rater reliability (IRR) of a novel transmembranous EMG (tmEMG) sensor as a non‐invasive technique for assessment of oral cavity and oropharyngeal muscles for neuromuscular pathology.